Oncology Generic Medicines - Additions
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)contractFind a Tender ↗Ref ocds-h6vhtk-029adf32014L0024active
Estimated value
—
goods
Awarded value
—
Suppliers
11
Lots
5
5 awarded
Published
22 Jun 2021
Description
Supply of oncology generic medicines to NHS Scotland
Scope
- Reference
- NP39721a
- Commercial tool
- Standalone contract
- Contract dates
This framework includes the option to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
- Main category
- goods
- CPV classifications
- 33600000
- Contract locations
- Scotland
Award criteria
Criteria the buyer will use to evaluate bids.
| Name | Description | Type | Weighting |
|---|---|---|---|
| Logistics | 5 | quality | — |
| — | 95 | price | — |
| Range of Presentations | 15 | quality | — |
| Extended Stability | 10 | quality | — |
| — | 75 | price | — |
Submission & procedure
- Procedure
- Open procedure
Award details· 5 awards
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
—
Award date
—
Contract start
—
Contract end
—
Lots · 5 total
Divisions of the contract. Each lot can be awarded separately.
| Lot | Title | Est. value | Status |
|---|---|---|---|
| 1 | Paclitaxel Albumin Powder for Suspension for Infusion | £588k | cancelled |
| 2 | Everolimus Tablets | £1.6m | cancelled |
| 6 | Pemetrexed Solution for Infusion | £2.5m | cancelled |
| 3 | Dasatinib Tablets | £5.5m | cancelled |
| 4 | Cabazitaxel, Fulvestrant and Vinorelbine | £6.9m | cancelled |